Mild renal pelvis dilatation: Implications and management

Fetal and Maternal Medicine Review

Volumn 10, Issue 3, 1998, Pages 153-161

  Cockell, Anna P ^a   Chitty, Lyn S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FOLLOW UP; KIDNEY PELVIS; PREDICTION; PRENATAL CARE; PRENATAL DIAGNOSIS; PYELECTASIS; REVIEW; RISK FACTOR; SOCIOECONOMICS; STANDARDIZATION; VESICOURETERAL REFLUX;

EID: 0032466971     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539598000333     Document Type: Review

References (31)

1. Hoddick WK, Filly RA, Mahony BS, Callen PW. Minimal fetal renal pyelectasis. J Ultrasound Med 1985; 4: 85-89.
2. Thompson MO, Thilaganathan B. Effect of routine screening for Down's syndrome on the significance of isolated fetal hydronephrosis. Br J Obstet Gynaecol 1998; 105: 860-64.
3. Wickstrom EA, Thangavelu M, Parilla BV, Tamura RK, Sabbagha RE. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality. Obstet Gynecol 1996; 88: 379-82.
4. Tibballs JM, De Bruyn R. Primary vesicoureteric reflux - how useful is postnatal ultrasound? Arch Dis Child 1996; 75: 444-447.
5. Ouzounian JG, Castro MA, Fresquez M, Al-Sulyman M, Kovacs BW. Prognostic significance of antenatally detected fetal pyelectasis. Ultrasound Obstet Gynecol 1996; 7: 424-28.
6. Anderson NG, Abbott GD, Mogridge N, Allan RB, Maling TM, Wells JE. Vesicoureteric reflux in the newborn: relationship to fetal renal pelvic diameter. Pediatr Nephrol 1997; 11: 610-16.
7. Scott JES, Renwick M. Urological anomalies in the Northern Region Fetal Abnormality Survey. Arch Dis Child 1993; 68: 22-26.
8. Scott JES, Wright B, Wilson G, Pearson IA, Matthews JNS, Rose PG. Measuring the fetal kidney with ultrasonography. Br J Urol 1995; 76: 769-74.
9. Corteville JE, Gray DL, Crane JP. Congenital hydronephrosis: Correlation of fetal ultrasonographic findings with infant outcome. Am J Obstet Gynecol 1991; 165: 384-88.
10. Robinson JN, Tice K, Abuhamad AZ. Effect of maternal hydration on fetal renal pyelectasis. Obstet Gynecol 1998; 92: 137-141.
11. Bates JA, Irving HC. Inability of color and spectral Doppler to identify fetal renal obstruction. J Ultrasound Med 1992; 11: 469-72.
12. Thomas DFM. Fetal uropathy. Br J Urol 1990; 66: 225-31.
13. Chudleigh P, Chitty LS, Wright E, Campbell S, Pembrey M. The association of aneuploidy and mild fetal pyelectasis in a selected population: The results of a multicentre study. Ultrasound Obstet Gynecol 1999; in press.
14. Dudley JA, Haworth JM, McGraw ME, Frank JD, Tizard EJ. Clinical relevance and implications of antenatal hydronephrosis. Arch Dis Child 1997; 76: F31-F34.
15. Adra AM, Mejides AA, Dennaoui MS, Beydoun SN. Fetal pyelectasis: Is it always "physiologic"? Am J Obstet Gynecol 1995; 173: 1263-66.
16. Dejter SW, Gibbons MD. The fate of infant kidneys with fetal hydronephrosis but initially normal postnatal sonograhy. J Urol 1989; 142: 661-62.
17. Gordon AC, Thomas FM, Irving RJA, Smith SEW. Prenatally diagnosed reflux: a follow-up study. Br J Urol 1990; 65: 407-12.
18. Najmaldin A, Burge DM, Atwell JD. Fetal vesicoureteric reflux. Br J Urol 1990; 65: 403-406.
19. Marra G, Barbieri G, Moioli C, Assael BM, Grumieri G, Caccamo ML. Mild fetal hydronephrosis indicating vesicoureteric reflux. Arch Dis Child 1994; 70: F147-F150.
20. Wickstrom EA, Maizels M, Sabbagha RE, Tamura RK, Cohen LC, Pergament E. Isolated fetal pyelectasis: assessment of risk for postnatal uropathy and Down syndrome. Ultrasound Obstet Gynecol 1996; 8: 236-40.
21. Chitty LS, Chudleigh P, Campbell S, Pembrey M. The clinical significance of mild renal pelvic dilatation: a population study. In preparation.
22. Morin L, Cendron M, Crombleholme TM, Garmel SH, Klauber GT, D'Alton ME. Minimal hydronephrosis in the fetus: clinical significance and implications for management. J Urol 1996; 155: 2047-49.
23. Blachar A, Blachar Y, Livne PM, Zurkowski L, Pelet D, Mogilner B. Clinical outcome and follow-up of prenatal hydronephrosis. Pediatr Nephrol 1994; 8: 30-5.
24. Wilson RD, Lessoway VA. Fetal pyelectasis: comparison of postnatal renal pathology with unilateral and bilateral pyelectasis. Prenat Diag 1997; 17: 451-55.
25. Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto FD. Fetal pyelectasis: A possible association with Down Syndrome. Obstet Gynecol 1990; 76: 58-61.
26. Nicolaides KH, Cheng HH, Abbas A, Snijders RJM, Gosden C. Fetal renal defects: associated malformations and chromosomal defects. Fetal Diagn Ther 1992; 7: 1-11.
27. Corteville JE, Dicke JM, Crane JP. Fetal pyelectasis and Down Syndrome: Is genetic amniocentesis warranted? Obstet Gynecol 1992; 79: 770-72.
28. Snijders RJM, Sebire NJ, Nicolaides KH. Assessment of risk. In: Snijders RJM, et al, Ultrasound markers for fetal chromosomal defects. London: Parthenon, 1996: 63-120.
29. Degani S, Leibovitz Z, Shapiro I, Gonen R, Obel G. Fetal pyelectasis in consecutive pregnancies: a possible genetic predisposition. Ultrasound Obstet Gynecol 1997; 10: 19-21.
30. Podevin G, Mandelbrot L, Vuillard E, Oury JF, Aigrain Y. Outcome of urological abnormalties prenatally diagnosed by ultrasound. Fetal Diagn Ther 1996; 11: 181-90.
31. Stocks A, Richards D, Frentzen B, Richard G. Correlation of prenatal renal pelvic anteroposterior diameter with outcome in infancy. J Urology 1996; 155: 1050-52.